NanoEntek Wins Patent Infringement Lawsuit Against Curiosis

[Asia Economy Reporter Jang Hyowon] NanoEnTek (CEO Jeong Chan-il) announced on the 28th that it won a patent infringement lawsuit filed against Curiosis.

The 62nd Civil Division of the Seoul Central District Court prohibited the production, import/export, sale, transfer, rental, and exhibition of Curiosis's infringing products FACSOMA and FACSCOPE, and ordered all infringing products to be destroyed.

The patent in question is for a "microparticle counting device," which is the core technology of the automated cell counter developed and sold by NanoEnTek. For cell counting, the device's camera captures images of the cells; since it sequentially moves and, depending on the sample, takes more than 100 images, the counting accuracy is high.

On the other hand, most domestic and foreign competitors' products without this patent take only one photo for counting, resulting in lower accuracy. NanoEnTek applies the technology utilizing this patent to products such as white blood cell and raw milk cell analyzers and automated cell counters, leading the global market.

A NanoEnTek representative stated that recently, the number of domestic and foreign companies infringing on their technology has increased, and they intend to sound the alarm, fully dedicating their efforts to protecting intellectual property rights as a technology-strong company and leading the protection of the company's value.

This content was produced with the assistance of AI translation services.